DNA Methylation Levels at the C3orf37 Loci Correlate With Prostate Cancer Grade.

Area of Science:

• Epigenetics
• Molecular Oncology
• Genomic Medicine

Background:

• Accurate prostate cancer diagnosis requires distinguishing between indolent and aggressive tumors.
• Pathological diagnosis alone may not always suffice for precise grading.

Purpose of the Study:

• To investigate if DNA methylation levels at specific genomic sites can serve as a diagnostic index for prostate cancer malignancy.
• To correlate DNA methylation with cancer grade and gene expression.

Main Methods:

• Utilized methylation-specific PCR (MSP) to quantify DNA methylation levels in cultured prostate cells and patient needle biopsy tissues.
• Identified and analyzed four candidate gene loci (BCAT1, C3orf37, PCDHA1-8, RAI1).
• Examined correlations between DNA methylation and gene expression in patient tissues.

Main Results:

• Significantly higher DNA methylation levels were observed in cancer cells compared to normal cells at the four candidate loci.
• DNA methylation near the C3orf37 gene correlated with prostate cancer grade, being higher in high-grade cancers.
• A tendency for correlation between DNA methylation and gene expression was noted at the PCDHA1 locus.

Conclusions:

• Quantitative DNA methylation analysis, particularly near the C3orf37 gene, shows potential as a biomarker for differentiating index from indolent prostate cancer.
• This epigenetic approach may aid in refining prostate cancer diagnosis and management strategies.